Prognostic value of pretreatment carcinoembryonic antigen, neuron‐specific enolase, and creatine kinase‐BB levels in sera of patients with small cell lung cancer

Cancer

Volumn 62, Issue 1, 1988, Pages 125-134

  Jaques, Gabriele ^a   Bepler, Gerold ^a   Holle, Rolf ^b   Wolf, Martin ^a   Hannich, Thomas ^a   Gropp, Glaus ^a   Havemann, Klaus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CREATINE KINASE; NEURON SPECIFIC ENOLASE;

BLOOD LEVEL; HISTOLOGY; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SMALL CELL; CREATINE KINASE; HUMAN; ISOENZYMES; LUNG NEOPLASMS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0023949165     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880701)62:1<125::AID-CNCR2820620122>3.0.CO;2-X     Document Type: Article

References (34)

1. Demonstration of tumor‐specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques
2. Demonstration of an antigen common to several varieties of neoplasia
3. The carcinoembryonic antigen assay in bronchogenic carcinoma
4. Plasma levels of CEA in bronchogenic cancer and chronic bronchitis
5. Measurements of CEA in patients with bronchogenic carcinoma
6. CEA in bronchial carcinoma staging and monitoring of radio‐ and chemotherapy
7. The value of carcinoembryonic antigen in patients with carcinoma of the lung
8. Carcinoembryonic antigen: A useful monitor of therapy of small cell lung cancer
9. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment
10. A study of immunreactive calcitonin, adrenocorticotrophic hormone and carcino‐embryonic antigen in lung cancer and other malignancies
11. Plasma CEA levels in small cell lung cancer: Correlation with stage, distribution of metastases, and survival
12. CEA: A useful prognostic marker of small cell lung cancer (Abstr)
13. Evidence for a new form of enolase in rat brain
14. The neurobiology of the brain enolase
15. Neuron‐specific enolase is a marker for peripheral and central neuroendocrine cells
16. High levels of immunoreactive nervous system‐specific enolase in sera of patients with neuroblastoma
17. Neuron‐specific enolase: A marker for disease extent and response to therapy in patients with small cell lung cancer
18. Neuron‐specific enolase as a new tumor marker
19. Potential utility of serum neuron‐specific enolase levels in small cell carcinoma of the lung
20. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures
21. The production of brain‐type creatine kinase in the serum of patients with oat‐cell carcinoma
22. Elevated serum creatine kinase BB levels in patients with small cell lung cancer
23. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines
24. Alternating versus sequential chemotherapy in small cell lung cancer (SCLC): A randomized German multicenter trial
25. Purification and characterization of human neuron‐specific enolase: Radioimmunoassay development
26. Thymosin immunotherapy in patients with small cell carcinoma of the lung
27. Evaluation of carcinoembryonic antigen in human mammary carcinoma
28. Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy
29. Immunocytochemical staining for CEA in small cell carcinoma of lung predicts clinical usefulness of the plasma assay
30. Evaluation of serum neuron‐specific enolase as a tumor marker for carcinoma of the lung
31. Evaluation of a radioimmunoassay for neuron‐specific enolase in small cell lung cancer
32. Neuron‐specific enolase: A useful diagnostic serum marker for small cell carcinoma of the lung
33. Serum neuron‐specific enolase: A marker for disease extent and response to therapy for SCLC
34. Creatine kinase B submit as a biomarker for small cell carcinoma of the lung: Comparison with γ‐enolase